(Q33914367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

9 November 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J W Stevens

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Montmartin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

339-349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947489%20AND%20SRC:MED&resulttype=core&format=json

Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Costs, effects and C/E-ratios alongside a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Statistical versus quantitative significance in the socioeconomic evaluation of medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Statistical inference for cost-effectiveness ratios.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Use of confidence intervals and sample size calculations in health economic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

A Bayesian approach to stochastic cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

The CE plane: a graphic representation of cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Bayesian estimation of cost-effectiveness ratios from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00004

Confidence intervals for cost/effectiveness ratios

21 January 2018

1 reference

12 December 2020

Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.

1 reference

12 December 2020

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

12 December 2020

Problems with interval estimates of the incremental cost-effectiveness ratio

1 reference

12 December 2020

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

12 December 2020

A note on confidence intervals in cost-effectiveness analysis

1 reference

12 December 2020

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

12 December 2020

The generalisability of pharmacoeconomic studies

1 reference

12 December 2020

Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results

1 reference

12 December 2020